SUBSCRIBE
SUBSCRIBE

Valeant Pharmaceuticals International

NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Biotech Beach
The Day In Review: Valeant Pharmaceuticals International Rises Despite Mixed Trial Results
September 12, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Hepatitis Drug From Valeant Pharmaceuticals International Fails Test
March 22, 2006
 · 
1 min read
The Day In Review: Biotech Lower After Fed Decision
October 19, 2005
 · 
1 min read
Load More
IN THE PRESS
Deals
Marathon Pharmaceuticals, LLC Prepares For Launch Of New Rare Disease Treatments By Selling Non-Strategic Products To Valeant Including Isuprel And Nitropress
February 23, 2015
 · 
2 min read
Business
Valeant Reports Fourth Quarter And Full Year 2014 Financial Results
February 23, 2015
 · 
3 min read
Deals
Dendreon Corporation Enters Into Amended Agreement With Valeant In Connection With Court-Supervised Sales Process
February 5, 2015
 · 
4 min read
Business
Valeant To Announce 2014 Fourth Quarter And Full Year Results On February 24, 2015
February 5, 2015
 · 
1 min read
Valeant Announces Redemption Of All Of The Approximately $500 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018
January 16, 2015
 · 
2 min read
Valeant Announces Pricing Of Private Offering Of Senior Notes
January 16, 2015
 · 
3 min read
Valeant Announces Launch Of Private Offering Of Senior Notes
January 15, 2015
 · 
3 min read
Valeant To Present At The J.P. Morgan 2015 Healthcare Conference
January 6, 2015
 · 
1 min read
Valeant To Hold Conference Call To Announce 2015 Financial Guidance
December 16, 2014
 · 
1 min read
Valeant Announces Redemption Of US$445.0 Million Aggregate Principal Amount Of Its Outstanding 6.875% Senior Notes Due 2018
December 1, 2014
 · 
2 min read
Load More